Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Annals of the New York Academy of Sciences|December 24, 2010
Structure-based design of anti-infectivesAnil K Agarwal, Colin W G FishwickAntiviral Research|February 24, 2015
Epoxide based inhibitors of the hepatitis C virus non-structural 2 autoproteaseJoseph Shaw, Colin W G Fishwick, Mark HarrisAntiviral Research|November 1, 2015
Identification of a lead like inhibitor of the hepatitis C virus non-structural NS2 autoproteaseJoseph Shaw, Mark Harris, Colin W G FishwickNature Reviews. Microbiology|June 17, 2010
Structure-based discovery of antibacterial drugsKatie J Simmons, Ian Chopra, Colin W G FishwickPharmaceuticals (Basel, Switzerland)|June 1, 2023
Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IVScott Grossman, Colin W G Fishwick, Martin J McPhillieDrug Discovery Today|May 12, 2015
Refining the chemical toolbox to be fit for educational and practical purpose for drug discovery in the 21st CenturyMarco Lolli, Sarah Narramore, Colin W G Fishwick, et al.Current Topics in Medicinal Chemistry|August 18, 2016
New Opportunities in the Structure-based Design of Anti-Protozoan AgentsJames A Gordon, Colin W G Fishwick, Martin J McPhillieMethods in Molecular Biology (Clifton, N.J.)|August 20, 2015
Identification of Receptor Tyrosine Kinase Inhibitors Using Cell Surface Biotinylation and Affinity IsolationAntony M Latham, Jayakanth Kankanala, Colin W G Fishwick, et al.Antimicrobial Agents and Chemotherapy|January 9, 2008
Linezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase centerKeith Miller, Colin J Dunsmore, Colin W G Fishwick, et al.Parasitology|June 18, 2013
An in silico structure-based approach to anti-infective drug discoveryFraser Cunningham, Martin J McPhillie, A Peter Johnson, et al.Pageof 8